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PURPOSE
Our hypothesis predicts that retinal blood vessels increase in density during early-stage
progression to moderate nonproliferative diabetic retinopathy (NPDR). The prevailing paradigm of
NPDR progression is that vessels drop out prior to abnormal, vision-impairing regrowth at late-
stage proliferative diabetic retinopathy (DR). However, surprising results for our previous
preliminary study1 with NASA’s VESsel GENeration Analysis (VESGEN) software showed that
vessels proliferated considerably during moderate NPDR compared to dropout at both mild and
severe NPDR. Validation of our hypothesis will support development of successful early-stage
regenerative therapies such as vascular repair by circulating angiogenic cells (CACs). The renin-
angiotensin system (RAS) is implicated in the pathogenesis of DR and in the function of CACs, a
critical bone marrow-derived population that is instrumental in vascular repair.
METHODS
Arterial and venous patterns were extracted from images of 6 normal control subjects and 3
early NPDR subjects (mild and moderate) obtained by Heidelberg Spectralis® 30 degree imaging
following fluorescein angiography (FA). The binary vascular patterns were mapped by VESGEN to
yield branching generations (Gx) and quantified by parameters that include densities of vessel
length (Lv), area (Av) and number (Nv). Peripheral blood of diabetics and controls was collected for
CD34+ CAC isolation. RAS gene expressions in CACs were measured by qPCR for Mas receptor
for Ang-(1-7). Vasoreparative function of CACs was assessed by migration ability toward CXCL12
(SDF-1) using QCM 5μM 96-well chemotaxis cell migration assay.
RESULTS
By VESGEN analysis, vessel density measured by Lv, Av, and Nv in early NPDR was greater
than in normal retina (Figure 1). For example, Lv was 2.00 ± 0.06E-2 px/px2 in NPDR veins for all
branching generations compared to 9.85 ± 0.68E-3 px/px2 in control, and 1.64 ± 0.13E-2 px/px2
compared to 9.18 ± 0.99E-3 px/px2 in arteries. Results, which are slightly updated from our
abstract submission, were confirmed by other parameters such as Av and Nv. The expression of
Mas in CACs was reduced in NPDR relative to control, indicating possible loss of compensation of
the protective RAS at this stage of DR. NPDR was associated with CD34+ CAC migratory
dysfunction toward CXCL12, which was corrected with Ang-(1-7) pretreatment prior to CXCL12
exposure.
CONCLUSIONS
For our ongoing longitudinal study, preliminary evidence by VESGEN indicates that vascular
density increased in early NPDR compared to normal retinas. The results are the first independent
confirmation of our previous study1 If validated by more complete analysis, the VESGEN
discovery is potentially of value for determining optimal therapies at early stages of NPDR, when
regenerative vascular treatments are more likely to be successful. These data further suggest the
protective RAS axis within diabetic CACs is lost early in DR and is associated with increased
vascular remodeling evidenced by VESGEN analysis.
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Figure 1 Increased Vascular Density in Early-Stage NPDR
Vessel density increased in both arteries and veins during early NPDR (a-c) compared to normal patients (d-f) in vascular trees
analyzed by NASA’s VESGEN software extracted from 30 degree Spectralis® fluorescein images. Branching generations in the arterial
and venous trees (pseudo-colored per legend for Branching Generations, G1-G7) were automatically analyzed by VESGEN according to
physiological vascular rules. All mapped vessels were enlarged slightly to visualize the small vessels. Vessel density was quantified by
VESGEN parameters such as densities of vessel length (Lv), area (Av) and number (Nv). For example, Lv was 2.00 ± 0.06E-2 px/px2 in
NPDR veins for all branching generations compared to 9.85 ± 0.68E-3 px/px2 in controls, and 1.64 ± 0.13E-2 px/px2 compared to 9.18 ±
0.99E-3 px/px2 in arteries. Results were confirmed by other parameters that include Av and Nv.
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